IP Verse

Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age Related Macular Degeneration Treated With Anti Vegf - EP3384049

PATENT ANALYSIS

Patent Details

Grant Date
Aug 2, 2023
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

AMGEN INC.

BOULT WADE TENNANT LLP

POHLMAN, SANDRA M.

WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you